skip to Global Navigation Bar skip to main content


homeHome > Investors > IR information > Securities Reports

Securities Reports

뉴스
No Subject Name Data Down
18 Stronger co-promotion ties with MSD a positive (Mirae) DAEWOONG 2011-07-20 Stronger_co-promotion_ties_with_MSD_a_positive(Mirae).pdf
17 Less affected by gov’t regulations (woori) DAEWOONG 2011-06-29 20110628_Daewoong_less_affected_by_gov’t_regulations(woori-5).pdf
16 Ursa Leading the Pack (Hana) DAEWOONG 2011-05-11 20110429_Daewoong_Ursa_Leading_the_Pack(hana-6).pdf
15 Distinguished risk management (woori) DAEWOONG 2011-02-23 20110218_Daewoong_Distinguished_risk_management(woori-4)(2).pdf
14 Time to improve in house drug development (Daewoo) DAEWOONG 2011-02-23 20110218_Daewoong_Time_to_improve_in-house_drug_development(daewoo-4)(2).pdf
13 Better earnings visibility needed (shinhan) DAEWOONG 2011-02-23 20110218_Daewoong_Better_earnings_visibility_needed(shinhan-4).pdf
12 Solid top line growth (KI) DAEWOONG 2011-02-18 20110218_Daewoong_Solid_top-line_growth(KI-5).pdf
11 Valuation at 5 year low (mirae) DAEWOONG 2011-02-18 20110208_Daewoong_Valuation_at_5-year_low(mirae-8).pdf
10 Earnings look good (shinhan) DAEWOONG 2011-02-18 20101104_Daewoong_Earnings_look_good(shinhan-4).pdf
9 Sales to growon enhanced core capability (Woori) DAEWOONG 2010-10-12 20101012_Daewoong_Sales_to_grow_on_enhanced_core_capability(woori-3).pdf
first page previous page 1  / 2  / 3  / 4  / 5  / next page last page